Health Care Insider Buying
50 health care companies had insider open-market purchases in the last 30 days. Ranked by dollar value, these are the ones the people who run them were buying with personal capital. All health care companies ยท How to read insider buying
Purchase value (30d)
50| # | Ticker / Company | Purchase value (30d) |
|---|---|---|
| 1 |  $TYRA Tyra Biosciences, Inc. | $200.01M |
| 2 |  $ATTO Attovia Therapeutics, Inc. | $25.07M |
| 3 |  $ZNTL Zentalis Pharmaceuticals, Inc. | $15.17M |
| 4 |  $ALMS ALUMIS INC. | $10.73M |
| 5 |  $IMTX Immatics N.V. | $7.50M |
| 6 |  $CYBN CYBIN INC. | $7.04M |
| 7 |  $TENX TENAX THERAPEUTICS, INC. | $4.93M |
| 8 |  $NIVF NewGenIvf Group Ltd | $4.16M |
| 9 |  $INBX Inhibrx Biosciences, Inc. | $4.00M |
| 10 |  $SLGL Sol-Gel Technologies Ltd. | $3.80M |
| 11 |  $CARL CARLSMED, INC. | $3.00M |
| 12 |  $COO COOPER COMPANIES, INC. | $1.88M |
| 13 |  $RLMD RELMADA THERAPEUTICS, INC. | $1.67M |
| 14 |  $KURA Kura Oncology, Inc. | $1.24M |
| 15 |  $ACOG Alpha Cognition Inc. | $1.16M |
| 16 |  $JUSH Jushi Holdings Inc. | $1.10M |
| 17 |  $EIKN Eikon Therapeutics, Inc. | $1.03M |
| 18 |  $ATEC Alphatec Holdings, Inc. | $1.01M |
| 19 |  $ATRA Atara Biotherapeutics, Inc. | $1000K |
| 20 |  $PRE Prenetics Global Ltd | $1000K |
| 21 |  $RGNX REGENXBIO Inc. | $949K |
| 22 |  $ELAN Elanco Animal Health Inc | $936K |
| 23 |  $PRTA PROTHENA CORP PUBLIC LTD CO | $695K |
| 24 |  $ABCL AbCellera Biologics Inc. | $570K |
| 25 |  $SRTS Sensus Healthcare, Inc. | $564K |
| 26 |  $NTHI NEONC TECHNOLOGIES HOLDINGS, INC. | $544K |
| 27 |  $TNON Tenon Medical, Inc. | $500K |
| 28 |  $ENOV Enovis CORP | $450K |
| 29 |  $MAIA MAIA Biotechnology, Inc. | $352K |
| 30 |  $SGRY Surgery Partners, Inc. | $305K |
| 31 |  $NATR NATURES SUNSHINE PRODUCTS INC | $294K |
| 32 |  $QNRX Quoin Pharmaceuticals, Ltd. | $280K |
| 33 |  $GRCE Grace Therapeutics, Inc. | $270K |
| 34 |  $TMCI TREACE MEDICAL CONCEPTS, INC. | $247K |
| 35 |  $AEON AEON Biopharma, Inc. | $243K |
| 36 |  $NAMS NewAmsterdam Pharma Co N.V. | $226K |
| 37 |  $MOBI Mobia Medical, Inc. | $219K |
| 38 |  $PODD INSULET CORP | $162K |
| 39 |  $BMRA BIOMERICA INC | $158K |
| 40 |  $CVM CEL SCI CORP | $138K |
| 41 |  $GRML Greenland Mines Ltd | $136K |
| 42 |  $YDES YD Bio Ltd | $129K |
| 43 |  $CTSO Cytosorbents Corp | $120K |
| 44 |  $INM InMed Pharmaceuticals Inc. | $118K |
| 45 |  $CVSI CV Sciences, Inc. | $115K |
| 46 |  $ALZN Alzamend Neuro, Inc. | $111K |
| 47 |  $TMDX TransMedics Group, Inc. | $109K |
| 48 |  $KRMD KORU Medical Systems, Inc. | $101K |
| 49 |  $BSX BOSTON SCIENTIFIC CORP | $100K |
| 50 |  $PLSE PULSE BIOSCIENCES, INC. | $100K |
Why sector matters for insider buying
Insider buying is easiest to read against its own sector. Company officers know their industry's cycle, not the market's, so a cluster of purchases across several health care names carries information that the same number of purchases spread across unrelated industries does not.
Only open-market purchases (SEC Form 4 transaction code P) are counted. Grants, option exercises and shares withheld for tax are compensation mechanics rather than a decision to buy, and counting them would rank sectors by payroll size.